Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Eriksson

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Disaster Medicine and Public Health Preparedness|April 4, 2020
Assessing Immediate Bed Availability and Barriers to Discharge in a United States Children's HospitalM Catherine Burgess, Debbie DeLorenzo, Carl Eriksson
Journal of Gastrointestinal and Liver Diseases : JGLD|April 1, 2011
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literatureCarl Eriksson, Anders Gustavsson, Thomas Kronvall, et al.
Disaster Medicine and Public Health Preparedness|February 5, 2026
Multi-hospital pediatric surge response to an RSV epidemic in a US state: Oregon, 2022Brendan Cleary, Matthew Hudkins, Peter Graven, et al.
Gut|April 6, 2018
Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort studyCarl Eriksson, Sara Rundquist, Yang Cao, et al.
JAMA Pediatrics|February 28, 2017
Accuracy of Prefilled "Code Cart" Epinephrine Syringes for Direct Administration of Small DosesMatt Hansen, Carl Eriksson, Nathan Mah, et al.
The American Journal of Emergency Medicine|August 20, 2017
Safety events in pediatric out-of-hospital cardiac arrestMatt Hansen, Carl Eriksson, Barbara Skarica, et al.
Therapeutic Advances in Gastroenterology|July 28, 2025
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH studyLinda Ryen, Isabella Visuri, Sara Karlqvist, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' replySara Rundquist, Michael C Sachs, Carl Eriksson, et al.
Advances in Simulation (London, England)|May 19, 2023
Measuring cognitively demanding activities in pediatric out-of-hospital cardiac arrestNathan Bahr, Jonathan Ivankovic, Garth Meckler, et al.
Scientific Reports|April 5, 2020
Genomic characterization and outcome of prosthetic joint infections caused by Staphylococcus aureusPeter Wildeman, Staffan Tevell, Carl Eriksson, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Disaster Medicine and Public Health Preparedness|April 4, 2020
Assessing Immediate Bed Availability and Barriers to Discharge in a United States Children's HospitalM Catherine Burgess, Debbie DeLorenzo, Carl Eriksson
Journal of Gastrointestinal and Liver Diseases : JGLD|April 1, 2011
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literatureCarl Eriksson, Anders Gustavsson, Thomas Kronvall, et al.
Disaster Medicine and Public Health Preparedness|February 5, 2026
Multi-hospital pediatric surge response to an RSV epidemic in a US state: Oregon, 2022Brendan Cleary, Matthew Hudkins, Peter Graven, et al.
Gut|April 6, 2018
Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort studyCarl Eriksson, Sara Rundquist, Yang Cao, et al.
JAMA Pediatrics|February 28, 2017
Accuracy of Prefilled "Code Cart" Epinephrine Syringes for Direct Administration of Small DosesMatt Hansen, Carl Eriksson, Nathan Mah, et al.
The American Journal of Emergency Medicine|August 20, 2017
Safety events in pediatric out-of-hospital cardiac arrestMatt Hansen, Carl Eriksson, Barbara Skarica, et al.
Therapeutic Advances in Gastroenterology|July 28, 2025
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH studyLinda Ryen, Isabella Visuri, Sara Karlqvist, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' replySara Rundquist, Michael C Sachs, Carl Eriksson, et al.
Advances in Simulation (London, England)|May 19, 2023
Measuring cognitively demanding activities in pediatric out-of-hospital cardiac arrestNathan Bahr, Jonathan Ivankovic, Garth Meckler, et al.
Scientific Reports|April 5, 2020
Genomic characterization and outcome of prosthetic joint infections caused by Staphylococcus aureusPeter Wildeman, Staffan Tevell, Carl Eriksson, et al.
Pageof 6